Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Minoxidil is cost-effective for regrowing hair on the scalp's top but not the front, requiring ongoing use.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

Women have smaller foreheads and different hairline shapes than men.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Isolated long hairs at the original hairline can help diagnose Frontal Fibrosing Alopecia.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Finasteride effectively treats hair loss in Korean men for at least 5 years, with V type responding better.

Carlos Oscar Uebel developed a hair transplant method that looks natural, has low risk, and shows full growth in 6-12 months.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.